Werewolf Therapeutics (HOWL) Market Capitalization (2021 - 2026)

Werewolf Therapeutics (HOWL) has reported Market Capitalization for 6 consecutive years, with $17.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 64.59% year-over-year to $17.5 million in Q2 2026; TTM through Jun 2026 was $17.5 million, a 64.59% decrease from a year earlier, with the FY2025 full-year figure at $30.6 million, down 53.85% from the prior year.
• Market Capitalization was $17.5 million for Q2 2026 at Werewolf Therapeutics, down from $40.3 million in the prior quarter.
• Over five years, Market Capitalization peaked at $280.5 million in Q1 2024 and troughed at $17.5 million in Q2 2026.
• A 5-year average of $93.7 million and a median of $92.2 million in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization soared 205.58% in 2024 and tumbled 84.5% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $64.4 million in 2022, then jumped by 134.25% to $151.0 million in 2023, then tumbled by 56.05% to $66.3 million in 2024, then slumped by 53.85% to $30.6 million in 2025, then tumbled by 42.85% to $17.5 million in 2026.
• The last three Market Capitalization figures came in at $17.5 million (Q2 2026), $40.3 million (Q1 2026), and $30.6 million (Q4 2025), per Business Quant data.